Literature DB >> 14534148

Regulation of leptin distribution between plasma and cerebrospinal fluid by cholecystokinin receptors.

Victoria Cano1, Laura Ezquerra, M Pilar Ramos, Mariano Ruiz-Gayo.   

Abstract

Cholecystokinin (CCK) is a postprandial hormone that elicits a satiating effect and regulates feeding behaviour. CCK has been shown to enhance the effect of leptin in several experimental paradigms. The goal of this work was to characterize the effect of endogenous CCK on plasma leptin content by using CCK receptor antagonists. Therefore, we administered SR-27897, a selective CCK1 receptor antagonist, and L-365260, a selective CCK2 receptor antagonist, to fed and food-deprived rats and determined plasma leptin concentration by enzyme immunoassay. Plasma insulin and glucose concentration as well as food intake were also determined. Under our conditions, SR-27897 increased plasma concentration of leptin both in fed and food-deprived rats. It also increased food intake as well as plasma concentration of insulin in fed animals. L-365260 increased plasma leptin concentration only in fed rats. In animals receiving exogenous leptin, CCK-8 increased the ratio between the concentration of leptin in cerebrospinal fluid and plasma. These results show that CCK receptor antagonists increases plasma concentration of leptin and suggest that endogenous CCK may facilitate the uptake of plasma leptin to the cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534148      PMCID: PMC1574067          DOI: 10.1038/sj.bjp.0705477

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats.

Authors:  A Lindén; P Södersten
Journal:  Physiol Behav       Date:  1990-12

2.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.

Authors:  E S Corp; J McQuade; T H Moran; G P Smith
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

4.  Regulation of activity in the hypothalamo-pituitary-adrenal axis is integral to a larger hypothalamic system that determines caloric flow.

Authors:  S F Akana; A M Strack; E S Hanson; M F Dallman
Journal:  Endocrinology       Date:  1994-09       Impact factor: 4.736

5.  [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.

Authors:  C Durieux; M Ruiz-Gayo; P J Corringer; F Bergeron; B Ducos; B P Roques
Journal:  Mol Pharmacol       Date:  1992-06       Impact factor: 4.436

6.  OB protein binds specifically to the choroid plexus of mice and rats.

Authors:  R Devos; J G Richards; L A Campfield; L A Tartaglia; Y Guisez; J van der Heyden; J Travernier; G Plaetinck; P Burn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor.

Authors:  A Funakoshi; K Miyasaka; S Kanai; M Masuda; Y Yasunami; T Nagai; S Ikeda; A Jimi; T Kawanami; A Kono
Journal:  Pancreas       Date:  1996-04       Impact factor: 3.327

8.  Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats.

Authors:  L Rinaman; G E Hoffman; J Dohanics; W W Le; E M Stricker; J G Verbalis
Journal:  J Comp Neurol       Date:  1995-09-18       Impact factor: 3.215

Review 9.  Biological actions of cholecystokinin.

Authors:  J N Crawley; R L Corwin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

10.  An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.

Authors:  A Funakoshi; K Miyasaka; H Shinozaki; M Masuda; T Kawanami; Y Takata; A Kono
Journal:  Biochem Biophys Res Commun       Date:  1995-05-25       Impact factor: 3.575

View more
  6 in total

Review 1.  Using the cerebrospinal fluid to understand ingestive behavior.

Authors:  Stephen C Woods; Aaron A May; Min Liu; Patrick Tso; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-12-05

2.  Anti-obesity Effects of Ginsenosides in High-Fat Diet-Fed Rats.

Authors:  Hyun-Jung Park; Ji Hyun Kim; Insop Shim
Journal:  Chin J Integr Med       Date:  2019-05-30       Impact factor: 1.978

3.  Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.

Authors:  Wenda Wu; Hui-Ren Zhou; Kaiyu He; Xiao Pan; Yoshiko Sugita-Konishi; Maiko Watanabe; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2014-01-02       Impact factor: 4.849

4.  CCK increases the transport of insulin into the brain.

Authors:  Aaron A May; Min Liu; Stephen C Woods; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-08-26

5.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

6.  Anticontractile Effect of Perivascular Adipose Tissue and Leptin are Reduced in Hypertension.

Authors:  Beatriz Gálvez-Prieto; Beatriz Somoza; Marta Gil-Ortega; Concha F García-Prieto; Ana I de Las Heras; M Carmen González; Silvia Arribas; Isabel Aranguez; Juliane Bolbrinker; Reinhold Kreutz; Mariano Ruiz-Gayo; Maria S Fernández-Alfonso
Journal:  Front Pharmacol       Date:  2012-06-05       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.